Intuitive Interference in Geometry: An Eye‐Tracking Study
Mind, Brain, and Education · 2020-05 · 14 (2) · 155-166
DOI: 10.1111/mbe.12231 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mind, Brain, and Education, online erschienen am 20.01.2020. Verfasst von Hanit Galili und 2 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Interference of irrelevant salient variables may cause difficulties for students. This study focused on eye tracking during the comparison of perimeters task, in which area is the interfering irrelevant salient variable. There were three trial types: congruent (larger area—larger perimeter), incongruent inverse (larger area—smaller perimeter), and incongruent equal (larger area—equal perimeter). Behavioral findings corroborated previous studies: congruent trials yielded higher accuracy and a shorter reaction time than did incongruent trials. Surprisingly, the area saliency could not be revealed in fixation location and duration measurements in incongruent inverse trials nor in the heat maps for incongruent inverse or incongruent equal trials, suggesting that such processing does not require overt attention; measures of attention shift from one geometrical shape to another were higher for incongruent equal trials, as was pupil dilation, suggesting that greater effort is associated with solving incongruent equal trials.
Zitieren
APA
Galili, H., Babai, R., & Stavy, R. (2020). Intuitive Interference in Geometry: An Eye‐Tracking Study. Mind, Brain, and Education, 14(2), 155-166. https://doi.org/10.1111/mbe.12231
Vancouver
Galili H, Babai R, Stavy R. Intuitive Interference in Geometry: An Eye‐Tracking Study. Mind, Brain, and Education. 2020;14(2):155-166. doi:10.1111/mbe.12231
BibTeX
@article{Galili2020,
author = {Galili, Hanit and Babai, Reuven and Stavy, Ruth},
title = {Intuitive Interference in Geometry: An Eye‐Tracking Study},
journal = {Mind, Brain, and Education},
year = {2020},
volume = {14},
number = {2},
pages = {155--166},
doi = {10.1111/mbe.12231}
}
EUVIMED